1 |
Galati F, Magri V, Arias-Cadena PA, Moffa G, Rizzo V, Pasculli M, Botticelli A, Pediconi F. Pregnancy-Associated Breast Cancer: A Diagnostic and Therapeutic Challenge. Diagnostics (Basel) 2023;13. [PMID: 36832092 DOI: 10.3390/diagnostics13040604] [Reference Citation Analysis]
|
2 |
Galati F, Rizzo V, Moffa G, Caramanico C, Kripa E, Cerbelli B, D’amati G, Pediconi F. Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes? Eur Radiol Exp 2022;6. [DOI: 10.1186/s41747-022-00289-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
3 |
Zhang R, Xu M, Zhou C, Ding X, Lu H, Ge M, Du L, Bu Y. The value of noncontrast MRI in evaluating breast imaging reporting and data system category 0 lesions on digital mammograms. Quant Imaging Med Surg 2022;12:4069-80. [PMID: 35919041 DOI: 10.21037/qims-21-968] [Reference Citation Analysis]
|
4 |
Du S, Gao S, Zhao R, Liu H, Wang Y, Qi X, Li S, Cao J, Zhang L. Contrast-free MRI quantitative parameters for early prediction of pathological response to neoadjuvant chemotherapy in breast cancer. Eur Radiol 2022. [PMID: 35267091 DOI: 10.1007/s00330-022-08667-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
5 |
Galati F, Trimboli RM, Pediconi F. Special Issue "Advances in Breast MRI". Diagnostics (Basel) 2021;11:2297. [PMID: 34943534 DOI: 10.3390/diagnostics11122297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Galati F, Moffa G, Pediconi F. Breast imaging: Beyond the detection. Eur J Radiol 2022;146:110051. [PMID: 34864426 DOI: 10.1016/j.ejrad.2021.110051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|